Información del artículo
Resumen
El oxido nítrico y el factor relajante del endotelio fueron consideradas la misma molécula moduladora del tono vascular a través de la formación estimulada de guanosina 3, 5 monofosfato. El oxido nítrico (NO) se produce durante la conversión de L-arginina a L-citrulina por las isoformas de oxido nítrico sintetasa (NOS), es un gas que modula varias funciones incluyendo la relajación del músculo liso, neurotransmisión, la citotoxicidad celular inmune, mecanismo de accion de agentes anestesicos y vias de nocicepcion. Esta revisión considera las acciones biológicas del oxido nítrico.
Palabras claves:
Oxido nítrc
oxido nítrico sintetasa
peroxinitrilos
Abstract
Nitric oxide and endothelium-derived relaxing factor were considered a single entity, modulating vascular tone through the stimulated formation of cyclic guanosine 3′,5′-monophosphate. Nitric oxide (NO), produced during the conversion of L-arginine to L-citrulline by NO synthase (NOS) isoforms, is a gaseous that mediates various functions, including smooth muscle relaxation, neurotransmission, immune cell cytotoxicity, effects of anesthetic agents and nociceptive pathways. This review will consider the biologic actions of nitric oxide.
Keywords:
Nitric oxide
nitric oxide synthase
peroxynitrite
El Texto completo está disponible en PDF
Referencias Bibliograficas
[(1)]
E. William Hurford.
Inhaled Nitric Oxide : Current Concepts.
The American Society of Anesthesiologists, (2003),
[(2)]
Izumi Harukuni, Anish Bhardwaj.
Mechanisms of Brain Injury after Global Cerebral Ischemia.
Neurol Clin, 24 (2006), pp. 1-21
[(3)]
Laurence L Brunton, John S Lazo, Keith L Parker. Goodman y Gilman`s The Pharmacological Basis of Therapeutics. 11 edicion : 395–397.
[(4)]
Mark J.D. Griffiths, Timothy W. Evans.
Inhaled Nitric Oxide Therapy in Adults.
N Engl J Med, 353 (December 22, 2005), pp. 25
[(5)]
J. Rodrigo, D. Alonso, A.P. Fernandez, J. Serrano, J.C. Lopez, J.M. Encinas, P. Fernandez Vizarra, S. Castro, M.A. Peinado, J.A. Pedrosa, A. Richard, Martinez Murillo, M. Santacana, M.L. Bentura, R.L.O. Uttenthal.
Nitric Oxide : synthesis, neuroprotection and neurotoxicity.
Anales del sistema sanitario de Navarra, 23 (May-Agost 2000), pp. 195-236
[(6)]
Paolo Tessari.
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study.
Am J Physiol Endocrinol Metab, 293 (2007), pp. E776-E782
[(7)]
Soo Jin Yang.
Low nitric oxide: a key factor underlying copper-deficiency teratogenicity.
Free Radic. Biol. Med, (2007),
[(8)]
A. Barrios, S.F. Raffan.
Oxido nítrico: una aproximacion a su utilidad clinica.
Rev. Col Anest, 22 (1994), pp. 23
[(9)]
Paresh Dandona.
Endothelial dysfunction and hypertension in diabetes mellitus.
Med Clin N Am, 88 (2004), pp. 911-931
[(10)]
F.F. Bolander Jr..
Prolactin activation of mammary nitric oxide synthase: molecular mechanisms.
Journal of Molecular Endocrinology, 28 (2002), pp. 45-51
[(11)]
Patrick Vallance, Norma Chan.
Endothelial function and nitric oxide : clinical relevance.
Heart, 85 (2001), pp. 342-350
[(12)]
Lionel H. Opie.
Heart Physiology.
From Cell to Circulation, Fourth Edition, (2004),
[(13)]
Matthew P. Coggins, Kenneth D. Bloch.
Nitric Oxide in the Pulmonary Vasculature.
Arterioscler Thromb Vasc Biol, 27 (2007),
[(14)]
Alex S. Evers, Mervyn Maze.
Anesthetic Pharmacology. Physiologic Principles and Clinical Practice, (2004),
[(15)]
K. Christin Roberts.
Acute exercise increases nitric oxide synthase activity in skeletal muscle.
Am J Physiol Endocrinol Metab, 277 (1999), pp. 390-394
[(16)]
Lars Ryden.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology and of the European Association for the study of diabetes.
Eur Heart J, (2007),
[(17)]
Stanley Muravchick, Richard J Levy.
Clinical Implications of Mitocondrial Dysfunction.
Anesthesiology, 105 (2006), pp. 819-837
[(18)]
L.A. Sigfrid.
Cytokines and nitric oxide inhibit the enzyme activity of catalase but not its protein or mRNA expression in insulin-producing cells.
Journal of Molecular Endocrinology, 31 (2003), pp. 509-518
[(19)]
M. Eugenia Cifuentes, Patrick J. Pagano.
Targeting reactive oxygen species in hypertension.
Current Opinion in Nephrology and Hypertension, 15 (2006), pp. 179-186
[(20)]
Nageswara R. Madamanchi, Marschall S. Runge.
Mitochondrial Dysfunction in Atherosclerosis.
Circ Res, 100 (2007), pp. 460-473
[(21)]
Hans H. Dietrich Ph.D, Ralph G. Dacey Jr. M.D..
Molecular Keys to the Problems of Cerebral Vasospasm.
Congress of Neurological Surgeons Volume, 46 (March 2000), pp. 517-530
[(22)]
Gentle Chikan.
Lipids: potential regulators of nitric oxide generation.
Am J Physiol Endocrinol Metab, 287 (2004), pp. E386-E389
[(23)]
Matthias Turina M.D., Mirjam Christ-Crain M.D., Hiram C. Polk Jr, MD..
Diabetes and hyperglycemia: Strict glycemic control.
Crit Care Med, 34 (2006), pp. S291-S300
[(24)]
M. Fitzgeral Sharyn.
Nitric oxide may be required to prevent hypertension at the onset of diabetes.
Am J Physiol Endocrinol Metab, 279 (2000), pp. E762-E768
[(25)]
Matthew R. Wei.
Calcium Channel Blockers : Their Pharmacologic and Therapeutic Role in Hypertension.
Am J Cardiovasc Drugs, 7 (2007), pp. 5-15
[(26)]
James R. Sowers.
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
Med Clin N Am, 88 (2004), pp. 63-82
[(27)]
Kris Vijayaraghavan.
The Renin Angiotensin System as a Therapeutic Target to Prevent Diabetes and its Complications.
Cardiol Clin, 23 (2005), pp. 165-183
[(28)]
Giuseppe Danilo Norata, Alberico Luigi Catapano.
Molecular Mechanisms Responsible for the Anti-Inflamatory and Protective Effect of High-Density Lipoprotein on the Endothelium.
High Blood Press Cardiovasc Prev, 14 (2007), pp. 21-31
[(29)]
Noriyuki Ouchi, Rei Shibata, Kenneth Walsh.
Cardioprotective Actions of Adiponectin.
High Blood Press Cardiovasc Prev, 14 (2007), pp. 69-73
[(31)]
Zhiheng He.
Microvascular complications of diabetes.
Endocrinol Metab Clin N Am, 33 (2004), pp. 215-238
[(32)]
Lynn A. Sokolnicki.
Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus.
Am J PhysiolEndocrinol Metab, 292 (2007), pp. E314-E318
[(33)]
A. Pantelis.
Insulin and Endothelin: An Interplay Contributing to Hypertension Development?.
J Clin Endocrinol Metab, 92 (February 2007), pp. 379-385
[(34)]
The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus.
The AACE System of Intensive Diabetes Self-Management— 2002 Update.
AACE Diabetes Guidelines, Endocr Pract, 8 (2002),
[(35)]
Joseph J. Torre.
America Association of clinical of Endocrinologists Medical Guidelines for Clinical practice for the diagnosis and treatment of Hypertension. AACE Hypertension Task Force.
AACE Hypertension Guidelines, Endocr Pract, 12 (2006),
[(36)]
Carmine Savoia, Ernesto L. Schiffrin.
Inflammation in Hypertension.
Current Opinion in Nephrology and Hypertension, 15 (2006), pp. 152-158
[(37)]
Paresh Dandona.
Proinflammatory Effects of Glucose and Anti-Inflammatory Effect of Insulin: elevance to Cardiovascular Disease.
Am J Cardiol, 99 (2007), pp. 15B-26B
[(38)]
Chiwaka Kimura.
Impairment of endothelial nitric oxide production by acute glucose overload.
Am J Physiol Endocrinol Metab, 280 (2001), pp. E171-E178
[(39)]
A. Lesley.
High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells.
Journal of Molecular Endocrinology, 33 (2004), pp. 797-803
[(40)]
Nichola Davis, Stuart Katz, Judith Wylie-Rosett.
The Effect of Diet on Entothelial Function.
Cardiology in Review, 15 (2007), pp. 62-66
[(41)]
Magali Araujo, Willian J. Welch.
Oxydative stress and nitric oxide in Kidney function.
Current Opinion in Nephrology and Hypertension, 15 (2006), pp. 72-77
[(42)]
Amy G. Tsai, Barbara Friesenecker, Pedro Cabrales, Nanae Hangai-Hoger.
Marcos Intaglietta. The vascular wall as a regulator of tissue oxygenation.
Current Opinion in Nephrology and Hypertension, 15 (2006), pp. 67-71
[(43)]
Donald E. Kohan.
The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure.
pp. 34-40
[(44)]
Tammo Ostendorf, Claudia Van Roeyen, Ralf Westenfeld, Alexander Gawlik, Masashi Kitahara, Emile De Heer, Dontscho Kerjaschki, Juergen Floege, Markus Ketteler.
Inducible Nitric Oxide Synthase-Derive Nitric Oxide Promotes Glomerular Angiogenesis via Upregulation of Vascular Endothelial Growth Factor Receptors.
J Am Soc Nephrol, 15 (2003), pp. 2307-2319
[(45)]
Marta Ruiz-Ortega.
Renal and vascular hypertension- induced inflammation: role of angiotensin II.
pp. 159-166
[(46)]
Tusty-Jiuan Hsieh.
Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells.
Journal of Endocrinology, 183 (2004), pp. 535-550
[(47)]
Kasem Nithipatikom.
Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells.
Am J Physiol Endocrinol Metab, 287 (2004), pp. E820-E827
[(48)]
Craig J. Hanke.
Endothelial cell nitric oxide inhibits aldosterone synthesis in zona glomerulosa cells: modulation by oxygen.
Am J Physiol Endocrinol Metab, 279 (2000), pp. E846-E854
[(49)]
Shigeki Miki, Naoshi Takeyama, Takaya Tanaka, Toshio Nakatani.
Inmune disfunction in endotoxicosis : Role of nitric oxide produced by inducible nitric oxide synthase.
Crit Care Med, 33 (2005),
[(50)]
David L. Maass.
Nitric oxide donors alter cardiomyocyte cytokine secretion and cardiac function.
Crit Care Med, 33 (2005), pp. 2794-2803
[(51)]
Noboru Toda M.D., Ph.D,, Hiroshi Toda M.D., Ph.D,, Yoshio Hatano.
Nitric Oxide. Involvement in the Effects of Anesthetic Agents.
Anestesiology, 107 (2007), pp. 822-842
[(52)]
Srinivas Pyati, Tong J. Gan.
Perioperative Pain Management.
Drugs, 21 (2007), pp. 185-211
Copyright © 2008. Revista Colombiana de Anestesiología
Opciones de artículo